Amsterdam: EU countries may start deploying Moderna COVID-19 (new coronavirus infection) (# If there is no character limit, add parentheses when it first appears Next week, shortly after authorities approved a second shot of the area on Wednesday, a more infectious variant of the virus added further urgency to the inoculation effort.
Immunization of 450 million people in the European Union could be essential to end a pandemic that killed about 1.9 million people worldwide. Countries are competing to include two more contagious and infectious outbreaks of variants found in South Africa and the United Kingdom.
“The second Moderna vaccine currently approved in the EU will allow another 160 million doses, and more vaccines will come,” said Ursula von der of the European Commission. -Chairman Leyen said on Wednesday.
She spoke hours after EU executives finally approved the vaccine deployment and the European Medicines Agency (EMA), the EU drug regulator, approved shots for use in people over the age of 18. Was there.
Modana said in the news that the first deliveries to European countries would begin next week.
Just over a year after the first outbreak of the virus was confirmed in China, EU approval is the fourth approval of the vaccine of US biotechnology company Moderna after the US, Canada and Israel, furthering the new gene mRNA technology. It is a verification. Use the.
The EU approved shots from Pfizer and BioNTech SE, also based on mRNA technology, two weeks ago.
The EMA has granted both conditional marketing authorizations rather than the UK-issued ultra-fast emergency use authorization. It states that EU regulators need a more detailed examination of the data.
A US company said in a post-news statement that additional approval of Modernashot is under consideration in Singapore, Switzerland and the United Kingdom.
Moderna shares rose more than 4% in early New York trading. The company’s value has skyrocketed by more than 450% since February last year as a pandemic hit the world and pharmaceutical companies rushed to develop shots.
Is it effective against variants?
The EU has ordered 160 million modelnashots, sufficient to vaccinate 80 million people in 27 member states, but the initial initial dose is expected to be small.
Moderna did not reveal volume details on Wednesday.
The vaccine was about 95% effective in preventing the disease in clinical trials, but found no serious safety issues.
CBG, the national drug authority in the Netherlands, has a Moderna vaccine Coronavirus It was detected in the United Kingdom, but warned that this should be confirmed by further investigation.
It must be stored and shipped frozen, but does not require the ultra-low temperature of the Pfizer / BioNTech vaccine. Once thawed, it can be kept at normal refrigerator temperature.
Stephen Evans, a professor of pharmacoepidemiology at the London School of Economics and Tropical Medicine, said the modana vaccine can be stored in the refrigerator for up to 30 days.
“Each vial has 10 doses. Once the vaccine reaches room temperature, the logistics of vaccine delivery are more complex than influenza vaccines, as everything must be used within up to 18 hours.” Added.
Synthetic genetic technology
EU countries began vaccination on December 27 and are working to catch up with countries where many are already vaccinated, such as the United Kingdom and Israel.
The campaign has already started unevenly, and German and French officials are dissatisfied with the slow progress.
Hundreds of thousands of Europeans have received Pfizer-BioNTech shots since the deployment began about a week ago. By comparison, the UK has given over one million vaccines in less than a month.
The Netherlands began vaccination with the shot on Wednesday and gave the first injection to a 39-year-old nurse in a care facility.
The Moderna vaccine is given twice every 28 days. Like Pfizer Shot, it relies on synthetic genes that can be produced and manufactured in weeks and can be produced on a larger scale faster than traditional vaccines.
On Monday, Moderna raised its 2021 production target to at least 600 million and 100 million.
Lonza Group of Switzerland has a contract to supply raw materials for vaccines, and Robi of Spain is assembling shots of filling finishing service.
Disclaimer: This post is auto-published from the agency feed without modification of the text and has not been reviewed by the editor.
Europe prepares for the deployment of the modelna vaccine amid growing fear of viral variants
Source link Europe prepares for the deployment of the modelna vaccine amid growing fear of viral variants